RT Journal Article
SR Electronic
T1 European Respiratory Society guidelines for the management of adult bronchiectasis
JF European Respiratory Journal
JO Eur Respir J
FD European Respiratory Society
SP 1700629
DO 10.1183/13993003.00629-2017
VO 50
IS 3
A1 Polverino, Eva
A1 Goeminne, Pieter C.
A1 McDonnell, Melissa J.
A1 Aliberti, Stefano
A1 Marshall, Sara E.
A1 Loebinger, Michael R.
A1 Murris, Marlene
A1 Cantón, Rafael
A1 Torres, Antoni
A1 Dimakou, Katerina
A1 De Soyza, Anthony
A1 Hill, Adam T.
A1 Haworth, Charles S.
A1 Vendrell, Montserrat
A1 Ringshausen, Felix C.
A1 Subotic, Dragan
A1 Wilson, Robert
A1 Vilaró, Jordi
A1 Stallberg, Bjorn
A1 Welte, Tobias
A1 Rohde, Gernot
A1 Blasi, Francesco
A1 Elborn, Stuart
A1 Almagro, Marta
A1 Timothy, Alan
A1 Ruddy, Thomas
A1 Tonia, Thomy
A1 Rigau, David
A1 Chalmers, James D.
YR 2017
UL https://publications.ersnet.org//content/50/3/1700629.abstract
AB Bronchiectasis in adults is a chronic disorder associated with poor quality of life and frequent exacerbations in many patients. There have been no previous international guidelines.The European Respiratory Society guidelines for the management of adult bronchiectasis describe the appropriate investigation and treatment strategies determined by a systematic review of the literature.A multidisciplinary group representing respiratory medicine, microbiology, physiotherapy, thoracic surgery, primary care, methodology and patients considered the most relevant clinical questions (for both clinicians and patients) related to management of bronchiectasis. Nine key clinical questions were generated and a systematic review was conducted to identify published systematic reviews, randomised clinical trials and observational studies that answered these questions. We used the GRADE approach to define the quality of the evidence and the level of recommendations. The resulting guideline addresses the investigation of underlying causes of bronchiectasis, treatment of exacerbations, pathogen eradication, long term antibiotic treatment, anti-inflammatories, mucoactive drugs, bronchodilators, surgical treatment and respiratory physiotherapy.These recommendations can be used to benchmark quality of care for people with bronchiectasis across Europe and to improve outcomes.The publication of the first ERS guidelines for bronchiectasis http://ow.ly/wQSO30dU0nE